NuCana plc - American Depositary Share (NCNA): Price and Financial Metrics
NCNA Price/Volume Stats
| Current price | $1.14 | 52-week high | $19.41 |
| Prev. close | $1.11 | 52-week low | $0.96 |
| Day low | $1.05 | Volume | 102,300 |
| Day high | $1.19 | Avg. volume | 126,036 |
| 50-day MA | $1.30 | Dividend yield | N/A |
| 200-day MA | $2.98 | Market Cap | 3.01M |
NCNA Stock Price Chart Interactive Chart >
NuCana plc - American Depositary Share (NCNA) Company Bio
NuCana plc develops anti-cancer medicines for ovarian, biliary, pancreatic, colorectal, haematology, oncology, and breast cancers. NuCana produces oncology medicines using a proprietary technology platform for cancer patients. The company was incorporated in 1997 and is based in Edinburgh, the United Kingdom.
NCNA Price Returns
| 1-mo | -5.79% |
| 3-mo | -37.53% |
| 6-mo | -68.29% |
| 1-year | -84.59% |
| 3-year | -98.35% |
| 5-year | -99.11% |
| YTD | -4.20% |
| 2024 | -83.91% |
| 2023 | -55.18% |
| 2022 | -72.27% |
| 2021 | -46.99% |
| 2020 | -26.39% |
Loading social stream, please wait...